The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-19
DOI
10.1007/s10549-020-05925-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutrophils as emerging therapeutic targets
- (2020) Tamás Németh et al. NATURE REVIEWS DRUG DISCOVERY
- Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review
- (2020) Iléana Corbeau et al. Cancers
- The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
- (2020) Ai-Ping Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine
- (2019) Michiko Imamura et al. Scientific Reports
- Immunotherapy and targeted therapy combinations in metastatic breast cancer
- (2019) Francisco J Esteva et al. LANCET ONCOLOGY
- A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab
- (2019) Jin Hong et al. Cancer Management and Research
- Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer
- (2018) Uiju Cho et al. PLoS One
- Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
- (2018) Tiziana Triulzi et al. BRITISH JOURNAL OF CANCER
- Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
- (2018) B. Losada et al. Clinical & Translational Oncology
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
- (2015) Martina Di Modica et al. Oncotarget
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer
- (2012) F. Andre et al. CLINICAL CANCER RESEARCH
- Increased hyaluronan content and stromal cell CD44 associate withHER2positivity and poor prognosis in human breast cancer
- (2012) Päivi Auvinen et al. INTERNATIONAL JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer
- (2010) Rupal Ramakrishnan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inflammatory Blood Monocytes Contribute to Tumor Development and Represent a Privileged Target To Improve Host Immunosurveillance
- (2010) S. Augier et al. JOURNAL OF IMMUNOLOGY
- Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review
- (2008) Yolanda Madarnas et al. CANCER TREATMENT REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started